Allison Wills 2023-10-13 Allison Wills 2023-10-13 Update on Managed Access and OBAs in Canada 26-02 Read More Allison Wills 2023-10-13 Allison Wills 2023-10-13 By the Numbers: Managed Access and Outcomes-Based Agreements 26-01 Read More Allison Wills 2023-10-06 Allison Wills 2023-10-06 POSTER: Leveraging real-world data from the private payer prior authorization process to operationalize outcomes-based agreements in Canada 25-01 Read More Allison Wills 2023-07-17 Allison Wills 2023-07-17 Health Equity in Canada by the Numbers 25-01 Read More Allison Wills 2023-07-13 Allison Wills 2023-07-13 Acing Equity 25-03 Read More Allison Wills 2023-07-13 Allison Wills 2023-07-13 A Level Playing Field 25-02 Read More Allison Wills 2023-04-24 Allison Wills 2023-04-24 Powering Up Patient Support Program Data 24-03 Read More Allison Wills 2023-04-13 Allison Wills 2023-04-13 Patient Support Program Data: A Uniquely Canadian Source of Evidence 24-02 Read More Allison Wills 2023-04-13 Allison Wills 2023-04-13 Patient Support Programs are Reaching New Heights 24-01 Read More Allison Wills 2023-01-17 Allison Wills 2023-01-17 Bringing Real-World Evidence to the Decision Table 23-03 Read More Allison Wills 2023-01-17 Allison Wills 2023-01-17 Breaking the RWE Acceptability Barrier 23-02 Read More Allison Wills 2023-01-16 Allison Wills 2023-01-16 RWE: Need to Know, Nice to Know 23-01 Read More Allison Wills 2022-10-18 Allison Wills 2022-10-18 Value-based healthcare: Defining the terms 22-01 Read More Allison Wills 2022-10-18 Allison Wills 2022-10-18 Centring Value in Healthcare 22-02 Read More Allison Wills 2022-10-18 Allison Wills 2022-10-18 A Bold New Vision for Value in Healthcare 22-03 Read More Allison Wills 2022-10-18 Allison Wills 2022-10-18 Une nouvelle vision audacieuse de la valeur dans les soins de santé 22-04 Read More Allison Wills 2022-07-18 Allison Wills 2022-07-18 Innovation in Specialty Medicine: a Pipeline to Watch Closely 21-02 Read More Allison Wills 2022-07-18 Allison Wills 2022-07-18 By the Numbers: The Specialty Drug Pipeline 21-01 Read More Allison Wills 2022-07-18 Allison Wills 2022-07-18 Making Meaning from Numbers 21-03 Read More Allison Wills 2022-04-18 Allison Wills 2022-04-18 By the Numbers: Private Payers and Specialty Pharmaceuticals 20-01 Read More Newer Posts Older Posts
Allison Wills 2023-10-13 Allison Wills 2023-10-13 Update on Managed Access and OBAs in Canada 26-02 Read More
Allison Wills 2023-10-13 Allison Wills 2023-10-13 By the Numbers: Managed Access and Outcomes-Based Agreements 26-01 Read More
Allison Wills 2023-10-06 Allison Wills 2023-10-06 POSTER: Leveraging real-world data from the private payer prior authorization process to operationalize outcomes-based agreements in Canada 25-01 Read More
Allison Wills 2023-07-17 Allison Wills 2023-07-17 Health Equity in Canada by the Numbers 25-01 Read More
Allison Wills 2023-04-24 Allison Wills 2023-04-24 Powering Up Patient Support Program Data 24-03 Read More
Allison Wills 2023-04-13 Allison Wills 2023-04-13 Patient Support Program Data: A Uniquely Canadian Source of Evidence 24-02 Read More
Allison Wills 2023-04-13 Allison Wills 2023-04-13 Patient Support Programs are Reaching New Heights 24-01 Read More
Allison Wills 2023-01-17 Allison Wills 2023-01-17 Bringing Real-World Evidence to the Decision Table 23-03 Read More
Allison Wills 2023-01-17 Allison Wills 2023-01-17 Breaking the RWE Acceptability Barrier 23-02 Read More
Allison Wills 2022-10-18 Allison Wills 2022-10-18 Value-based healthcare: Defining the terms 22-01 Read More
Allison Wills 2022-10-18 Allison Wills 2022-10-18 A Bold New Vision for Value in Healthcare 22-03 Read More
Allison Wills 2022-10-18 Allison Wills 2022-10-18 Une nouvelle vision audacieuse de la valeur dans les soins de santé 22-04 Read More
Allison Wills 2022-07-18 Allison Wills 2022-07-18 Innovation in Specialty Medicine: a Pipeline to Watch Closely 21-02 Read More
Allison Wills 2022-07-18 Allison Wills 2022-07-18 By the Numbers: The Specialty Drug Pipeline 21-01 Read More
Allison Wills 2022-04-18 Allison Wills 2022-04-18 By the Numbers: Private Payers and Specialty Pharmaceuticals 20-01 Read More
